Board recommends Final Dividend
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2017, inter alia, has recommended a final dividend of Rs. 9.00/- (Rupees Nine only) per equity share of Rs. 2/- each for the financial year ended March 31, 2017, for the approval of the shareholders of the Company at the ensuing Annual General Meeting. Outcome of Board Meeting
Press Release and Analyst presentation on Q4FY17 & FY17 Results - With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q4FY17 & FY17 earnings and business updates and the same will be uploaded on the website of the Company. Board approves Dividend
Outcome of the Board Meeting held on 26th May, 2017 - The Board of Directors at its meeting held today i.e. 26th May, 2017 recommended a final dividend of Rs. 9.00/- (Rupees Nine only) per equity share of Rs. 2/- each for the financial year ended 31st March, 2017, for the approval of the shareholders of the Company at the ensuing Annual General Meeting. Standalone And Consolidated Audited Financial Statements Of The Company As Per Indian Accounting Standards (Ind AS) For The Quarter And Financial Year Ended 31St March, 2017
In continuation of our letter dated 17th May, 2017 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') the Board of Directors at its meeting held today i.e. 26th May, 2017, has, inter alia approved the Standalone and Consolidated Audited Financial Statements of the Company as per Indian Accounting Standards (Ind... Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alkem Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report. Details Of The Voting Results Of The Postal Ballot Process And Remote E-Voting - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In continuation of our letter dated 20th April, 2017 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot process (including Remote E-voting) in the prescribed format alongwith the Scrutinizer's Report. Press Release
In furtherance to the intimation captioned 'Update on US FDA Inspection at Alkem's Baddi Facility' dated 10th March, 2017, this is to inform you that the US FDA has issued an Establishment Inspection Report (EIR) for its Baddi manufacturing facility which was inspected in March 2017. The inspection has now been closed by the US FDA. In response to the Form 483 issued by the US FDA, the Company had submitted a detailed corrective and preventive... Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alkem Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Intimation Of Conference Call On Q4FY17 & FY17 Financial Results
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY17 & FY17 financial results and business updates will be held on Friday, 26th May, 2017 at 5.30 P.M. Please find attached herewith the conference call details. Kindly take note of the same.